
Journal of the American Chemical Society p. 11315 - 11322 (1994)
Update date:2022-08-03
Topics:
Halcomb
Huang
Wong
Chemical and enzymatic methods have been developed for the synthesis of the oligosaccharides NeuAcα2 → 3Galβ1 → 4GlcNAcβ1 → 3Gal and NeuAcα2 → 3Galβ1 → 4(Fucα1 → 3)GlcNAcβ1 → 3Gal as inhibitors for H. pylori and E-selectin, respectively. Gal, NeuAc, and Fuc were incorporated sequentially into the synthetic primer GlcNAcβ1 → 3GalβOEt by the corresponding glycosyltransferases to give both the tetrasaccharide and the pentasaccharide. This solution-phase strategy was then extended to the solid-phase synthesis of the tetrasaccharide. A disaccharide primer was first attached to controlled pore glass via a spacer group containing an ester bond, followed by enzymatic incorporation of Gal and NeuAc. Two to three equivalents of sugar nucleotides were used in the enzymatic glycosylation, and the conversion for each step was found to be >98% as indicated in the analysis of products released by treatment with hydrazine.
View Morezhejiang huangyan wanfeng pharm chem co.ltd
Contact:+86-576- 84160728
Address:No. 5 Dazha Road, Economic,Development Zone(JiangKou), Zhejiang, China
Contact:+86-22-26358246
Address:601-4-20, Fujiayuan, Tiantai Road, Hebei District, Tianjin, China
Shanghai Coupling Pharmaceutical R&D Co., Ltd.(expird)
Contact:+86 021 50106671
Address:403 Room No.4 Buiding, No. 526 Ruiqing Road, Shanghai Zhangjiang Hi-Tech Park
Beijing Apis Biotechnology Co., Ltd.
Contact:86-010-67856775-8551
Address:NO.4PUHUANGYU ROAD,FENTAI DISTRICT, BEIJING, CHINA
Doi:10.1002/chem.201402205
(2014)Doi:10.1248/cpb.42.1590
(1994)Doi:10.1021/acs.joc.6b02890
(2017)Doi:10.1021/ja00453a035
(1977)Doi:10.1021/ja01180a078
(1949)Doi:10.1002/jhet.5570320115
(1995)